🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: HER2 Testing

Found 205 matching trials

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

N/A

The study is planned to observe and document the therapeutic decision-makin...

Status

Recruiting

Location

"Elena Venizelou" General Hospital, Department of Surgery

Start Date

2025-04-01

Trial ID

NCT07389408

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

PHASE1

This clinical trial tests the feasibility and utility of a biology guided t...

Status

Not Yet Recruiting

Location

City of Hope Medical Center

Start Date

2026-12-19

Trial ID

NCT07590583

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Bone Scan Computed Tomography Electronic Health Record Review Magnetic Resonance Imaging Positron Emission Tomography Treatment Planning Treatment Regimen

A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany

N/A

This non-interventional study will collect data from routine diagnostics on...

Status

Completed

Location

Klinikum Augsburg; Institut für Pathologie

Start Date

2016-03-04

Trial ID

NCT02666261

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

PHASE2

This phase II trial compares the effect of usual treatment of docetaxel che...

Status

Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-03-03

Trial ID

NCT05408845

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Docetaxel Echocardiography Test Magnetic Resonance Imaging Multigated Acquisition Scan Questionnaire Administration Trastuzumab Trastuzumab Deruxtecan Trastuzumab Emtansine

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

PHASE2

This phase II trial tests the accuracy of functional imaging (FFNP)-positro...

Status

Recruiting

Location

Siteman Cancer Center at Washington University

Start Date

2024-07-22

Trial ID

NCT06179303

Treatments Being Tested

Abemaciclib Anastrozole Biospecimen Collection Computed Tomography Diagnostic Imaging Testing Exemestane Fludeoxyglucose F-18 Fluorine F 18 Fluoro Furanyl Norprogesterone Fulvestrant Gonadotropin-releasing Hormone Analog Letrozole Positron Emission Tomography Tamoxifen Therapeutic Estradiol

Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.

EARLY_PHASE1

Gliomas are a heterogeneous group of tumors arising from glial cells in the...

Status

Recruiting

Location

Biogenea Pharmaceuticals Ltd

Start Date

2025-07-01

Trial ID

NCT07077616

Treatments Being Tested

Biological: personalized vaccine Based on genetic and transcriptional sequencing information, personalized peptide vaccines would be designed and produced;

Level of HER2-neu Gene Amplification an Response to Trastuzumab

N/A

Primary objective of the study is to evaluate the correlation between level...

Status

Unknown

Location

Istituto Clinco Humanitas

Start Date

2009-03

Trial ID

NCT00874146

Treatments Being Tested

Fluorescent in-situ hybridization (FISH)

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

This is a prospective examination of tumor material of breast cancer patien...

Status

Completed

Location

Multiple Locations

Start Date

2014-08

Trial ID

NCT02244580

Treatments Being Tested

MammaTyper™

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

N/A

This is a worldwide, multicenter, non-interventional, retrospective study o...

Status

Completed

Location

Research Site

Start Date

2021-05-28

Trial ID

NCT04807595

Treatments Being Tested

None (Observational study)

Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.

PHASE2

The primary objetive is to assess the capacity of the RAD51-foci score to p...

Status

Completed

Location

H Clinic de Barcelona

Start Date

2022-03-25

Trial ID

NCT05340413

Treatments Being Tested

Olaparib

Previous Next